| Product Code: ETC7548831 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India neuromyelitis optica treatment market import shipments demonstrated a steady growth trend with a CAGR of 5.3% from 2020 to 2024. However, there was a slight slowdown in growth between 2023 and 2024, with a growth rate of 1.2%. Overall, the market expanded consistently but with a moderated pace in the most recent period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neuromyelitis Optica Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Neuromyelitis Optica Treatment Market - Industry Life Cycle |
3.4 India Neuromyelitis Optica Treatment Market - Porter's Five Forces |
3.5 India Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 India Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 India Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Neuromyelitis Optica Treatment Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 India Neuromyelitis Optica Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuromyelitis optica in India |
4.2.2 Growing awareness about the condition and available treatment options |
4.2.3 Advances in medical research leading to the development of more effective treatments |
4.2.4 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 High cost associated with neuromyelitis optica treatment |
4.3.2 Limited access to specialized healthcare facilities in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new treatment options |
4.3.4 Lack of skilled healthcare professionals with expertise in treating neuromyelitis optica |
5 India Neuromyelitis Optica Treatment Market Trends |
6 India Neuromyelitis Optica Treatment Market, By Types |
6.1 India Neuromyelitis Optica Treatment Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Neuromyelitis Optica Spectrum Disorder with Aquaporin-4 Antibodies, 2021- 2031F |
6.1.4 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Neuromyelitis Optica Spectrum Disorder without Aquaporin-4 Antibodies, 2021- 2031F |
6.2 India Neuromyelitis Optica Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Plasma Exchange Therapy, 2021- 2031F |
6.2.4 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Immunoglobulin Therapy, 2021- 2031F |
6.3 India Neuromyelitis Optica Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, By C5 Protein Inhibitor, 2021- 2031F |
6.3.3 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Oral Corticosteroid, 2021- 2031F |
6.3.4 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Non-Steroid Immunosuppressive Drugs, 2021- 2031F |
6.3.5 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Neuromyelitis Optica Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 India Neuromyelitis Optica Treatment Market, By End- Users |
6.5.1 Overview and Analysis |
6.5.2 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 India Neuromyelitis Optica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neuromyelitis Optica Treatment Market Import-Export Trade Statistics |
7.1 India Neuromyelitis Optica Treatment Market Export to Major Countries |
7.2 India Neuromyelitis Optica Treatment Market Imports from Major Countries |
8 India Neuromyelitis Optica Treatment Market Key Performance Indicators |
8.1 Number of patients diagnosed with neuromyelitis optica annually |
8.2 Adoption rate of new treatment modalities in the market |
8.3 Patient satisfaction and quality of life improvement post-treatment |
8.4 Rate of adverse events or complications associated with current treatment options |
8.5 Research and development investment in innovative therapies for neuromyelitis optica |
9 India Neuromyelitis Optica Treatment Market - Opportunity Assessment |
9.1 India Neuromyelitis Optica Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 India Neuromyelitis Optica Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Neuromyelitis Optica Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 India Neuromyelitis Optica Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Neuromyelitis Optica Treatment Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 India Neuromyelitis Optica Treatment Market - Competitive Landscape |
10.1 India Neuromyelitis Optica Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Neuromyelitis Optica Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here